Key statistics dashboard for HeartSciences Inc. (HSCS). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process.
Stock Data
| Price | $3.79 |
| Market Cap | $8M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -1.07 |
| Price / Book | -6.21 |
| P/S | 1643.88 |
| P/FCF | -0.01 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -2908.83% |
| EBIT Margin | -209733.08% |
| EBITDA Margin | -209669.95% |
| Operating Margin | -209733.08% |
| Net Margin | -227024.23% |
Financial Health
| Current Ratio | 144.11 |
| Quick Ratio | 72.57 |
| Cash Ratio | 5.31 |
| Debt / Equity | -1.97 |
| Debt / Assets | 0.11% |
| Interest Coverage | -11.78 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -31.71 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 1017.00 |
| Cash per share | 8.15 |
| FCF per share | -360.97 |
| Tangible Book Value per share | 563.80 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 3 |
| Avg rating (1-5) | 1.00 |
Related companies: AMIX · BCLI · BMRA · GBS · IBO · MTNB · MYNZ
Explore sector: Healthcare · Medical - Devices
More sections of HSCS: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks